SARS-CoV-2 and HIV-1: Should HIV-1-Infected Individuals in Sub-Saharan Africa Be Considered a Priority Group for the COVID-19 Vaccines?
Since its emergence in 2019 SARS-CoV-2 has proven to have a higher level of morbidity and mortality compared to the other prevailing coronaviruses. Although initially most African countries were spared from the devastating effect of SARS-CoV-2, at present almost every country has been affected. Alth...
Guardado en:
Autores principales: | Wilson Lewis Mandala, Michael K. P. Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c80ddb6e6efb4dd4adf9155a53ae5d42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The influence of HIV infection and antiretroviral treatment on pulmonary function in individuals in an urban setting in sub-Saharan Africa
por: Oda E. van den Berg, et al.
Publicado: (2021) -
Differences in Perceived Risk of Contracting SARS-CoV-2 during and after the Lockdown in Sub-Saharan African Countries
por: Uchechukwu Levi Osuagwu, et al.
Publicado: (2021) -
Integrating diabetes, hypertension and HIV care in sub-Saharan Africa: a Delphi consensus study on international best practice
por: Geoff McCombe, et al.
Publicado: (2021) -
Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in sub-Saharan Africa: a systemic review and meta-analysis
por: Mohammed H, et al.
Publicado: (2018) -
The response to Hepatitis B virus vaccine in HIV-infected patients (HIV/AIDS counseling and care center in Kermanshah)
por: K Alaei, et al.
Publicado: (2004)